Michael F. Mullarkey

1.5k total citations
29 papers, 1.2k citations indexed

About

Michael F. Mullarkey is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael F. Mullarkey has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 8 papers in Immunology and Allergy and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael F. Mullarkey's work include Asthma and respiratory diseases (14 papers), Allergic Rhinitis and Sensitization (6 papers) and Inhalation and Respiratory Drug Delivery (5 papers). Michael F. Mullarkey is often cited by papers focused on Asthma and respiratory diseases (14 papers), Allergic Rhinitis and Sensitization (6 papers) and Inhalation and Respiratory Drug Delivery (5 papers). Michael F. Mullarkey collaborates with scholars based in United States, Ireland and Canada. Michael F. Mullarkey's co-authors include John S. Hill, Kenneth K. Takemoto, D. J. Webb, K. K. Takemoto, Garrick Bailey, Brent A. Blumenstein, Winston Andrade, Leonard C. Altman, W. Michael Hairfield and Claude F. Garon and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Michael F. Mullarkey

26 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael F. Mullarkey United States	17	556	356	314	290	145	29	1.2k
P Litoux France	14	59 0.1×	118 0.3×	20 0.1×	88 0.3×	138 1.0×	95	765
Cecilia Buonsanti United States	15	440 0.8×	249 0.7×	284 0.9×	77 0.3×	1.5k 10.2×	17	2.2k
Rahul Suresh United States	10	128 0.2×	70 0.2×	112 0.4×	21 0.1×	207 1.4×	23	804
B N Hudspith United Kingdom	21	593 1.1×	106 0.3×	271 0.9×	240 0.8×	379 2.6×	48	1.3k
Pierre‐Joseph Royer France	18	185 0.3×	123 0.3×	199 0.6×	166 0.6×	492 3.4×	38	1.4k
Julie Bérubé Canada	20	195 0.4×	242 0.7×	270 0.9×	79 0.3×	702 4.8×	41	1.5k
Edy Y. Kim United States	17	227 0.4×	170 0.5×	256 0.8×	52 0.2×	761 5.2×	40	1.5k
C.R. Darley United Kingdom	20	56 0.1×	119 0.3×	29 0.1×	43 0.1×	154 1.1×	56	1.1k
Volker Stephan Germany	18	471 0.8×	68 0.2×	361 1.1×	474 1.6×	345 2.4×	39	1.6k
H. C. Hoogsteden Netherlands	21	404 0.7×	179 0.5×	468 1.5×	179 0.6×	537 3.7×	37	1.2k

Countries citing papers authored by Michael F. Mullarkey

Since Specialization

Citations

This map shows the geographic impact of Michael F. Mullarkey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael F. Mullarkey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael F. Mullarkey more than expected).

Fields of papers citing papers by Michael F. Mullarkey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael F. Mullarkey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael F. Mullarkey. The network helps show where Michael F. Mullarkey may publish in the future.

Co-authorship network of co-authors of Michael F. Mullarkey

This figure shows the co-authorship network connecting the top 25 collaborators of Michael F. Mullarkey. A scholar is included among the top collaborators of Michael F. Mullarkey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael F. Mullarkey. Michael F. Mullarkey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mullarkey, Michael F., et al.. (2025). Hepatitis E virus screening in Irish blood donors: Seven years of individual donation nucleic acid testing reveals a frequent blood donor infection—but what is the risk?. Transfusion Medicine.

Mullarkey, Michael F., et al.. (2025). Carvedilol is associated with lower mortality than other nonselective beta-blockers in patients with cirrhosis. Baylor University Medical Center Proceedings. 38(4). 412–418.

Mullarkey, Michael F., et al.. (2020). Factitious Gastrointestinal Bleeding: A Case Series and Review. The American Journal of the Medical Sciences. 362(5). 516–521.

Schwartz, Howard J., Malcolm N. Blumenthal, Sheldon R. Braun, et al.. (1996). A Comparative Study of the Clinical Efficacy of Nedocromil Sodium and Placebo. CHEST Journal. 109(4). 945–952. 22 indexed citations

Mullarkey, Michael F.. (1995). Immunosuppressive Therapy for Asthma. Allergy and Asthma Proceedings. 16(2). 81–84. 6 indexed citations

Mullarkey, Michael F., K M Leiferman, Margot S. Peters, et al.. (1994). Human cutaneous allergic late-phase response is inhibited by soluble IL-1 receptor.. The Journal of Immunology. 152(4). 2033–2041. 46 indexed citations

Stempel, David A., Joyce K. Lammert, & Michael F. Mullarkey. (1991). Use of methotrexate in the treatment of steroid-dependent adolescent asthmatics.. PubMed. 67(3). 346–8. 29 indexed citations

Mullarkey, Michael F.. (1991). Methotrexate and asthma. Journal of Allergy and Clinical Immunology. 88(2). 272–274. 5 indexed citations

Mullarkey, Michael F., et al.. (1990). Long-Term Methotrexate Treatment in Corticosteroid-Dependent Asthma. Annals of Internal Medicine. 112(8). 577–581. 81 indexed citations

10.

Mullarkey, Michael F.. (1988). Eosinophilic nonallergic rhinitis. Journal of Allergy and Clinical Immunology. 82(5). 941–949. 27 indexed citations

11.

Mullarkey, Michael F., Winston Andrade, Brent A. Blumenstein, & Garrick Bailey. (1988). 54 Methotrexate in the treatment of corticosteroid-dependent asthma: A double-blind crossover study with follow-up. Journal of Allergy and Clinical Immunology. 81(1). 182–182. 1 indexed citations

12.

Mullarkey, Michael F., et al.. (1988). Methotrexate in the Treatment of Corticosteroid-Dependent Asthma. New England Journal of Medicine. 318(10). 603–607. 201 indexed citations

13.

Mullarkey, Michael F., et al.. (1988). Propagation and Characterization of Human Blood Basophils. International Archives of Allergy and Immunology. 86(3). 267–280. 13 indexed citations

14.

Mullarkey, Michael F.. (1982). Eosinophilic Nonallergic Rhinitis: A Review. Allergy and Asthma Proceedings. 3(3). 405–407. 1 indexed citations

15.

Webb, D. Robert, et al.. (1982). Bitolterol mesylate aerosol in chronic bronchial asthma. Journal of Allergy and Clinical Immunology. 69(1). 116–116. 3 indexed citations

16.

Altman, Leonard C., John S. Hill, W. Michael Hairfield, & Michael F. Mullarkey. (1981). Effects of Corticosteroids on Eosinophil Chemotaxis and Adherence. Journal of Clinical Investigation. 67(1). 28–36. 107 indexed citations

17.

Howley, Peter M., Michael F. Mullarkey, K. K. Takemoto, & Malcolm A. Martin. (1975). Characterization of human papovavirus BK DNA. Journal of Virology. 15(1). 173–181. 51 indexed citations

18.

Mullarkey, Michael F.. (1974). Viral Photoinactivation and Oncogenesis. New England Journal of Medicine. 290(6). 343–343. 6 indexed citations

19.

Takemoto, Kenneth K. & Michael F. Mullarkey. (1973). Human Papovavirus, BK Strain: Biological Studies Including Antigenic Relationship to Simian Virus 40. Journal of Virology. 12(3). 625–631. 114 indexed citations

20.

Cathcart, E S, et al.. (1970). AMYLOIDOSIS: AN EXPRESSION OF IMMUNOLOGICAL TOLERANCE ?. The Lancet. 296(7674). 639–640. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact